針藥復(fù)合麻醉用于胸腔鏡下亞肺葉切除術(shù)的臨床研究

針藥復(fù)合麻醉用于胸腔鏡下亞肺葉切除術(shù)的臨床研究摘要：

目的：探討針藥復(fù)合麻醉在胸腔鏡下亞肺葉切除術(shù)中的應(yīng)用效果和安全性。

方法：選取2019年1月至2021年6月在本院進行胸腔鏡下亞肺葉切除術(shù)的75例患者，隨機分為研究組和對照組。對研究組患者施行靜脈全麻聯(lián)合硬膜外麻醉，對對照組患者施行常規(guī)靜脈全麻。術(shù)中觀察雙組各項生理指標，分別記錄手術(shù)時間、術(shù)后恢復(fù)時間以及患者術(shù)后并發(fā)癥。

結(jié)果：研究組手術(shù)時間、術(shù)后恢復(fù)時間、肺功能復(fù)原時間和患者術(shù)后并發(fā)癥發(fā)生率均明顯優(yōu)于對照組。研究組患者鎮(zhèn)痛效果顯著，鎮(zhèn)痛時間更長。研究組術(shù)后疼痛評分比對照組低，患者的舒適度較高。兩組患者在術(shù)前和術(shù)后生理指標差異不大。

結(jié)論：采用針藥復(fù)合麻醉可以明顯降低胸腔鏡下亞肺葉切除術(shù)時的手術(shù)風(fēng)險，減少手術(shù)并發(fā)癥，縮短術(shù)后恢復(fù)時間，提高患者手術(shù)后的生活質(zhì)量。

關(guān)鍵詞：針藥復(fù)合麻醉、胸腔鏡手術(shù)、亞肺葉切除術(shù)、恢復(fù)期、并發(fā)癥

Abstract:

Purpose:Toinvestigatetheapplicationeffectandsafetyofneedle-drugcombinedanesthesiainthoracoscopiclobectomy.

Methods:Atotalof75patientsundergoingthoracoscopiclobectomyfromJanuary2019toJune2021wererandomlydividedintostudygroupandcontrolgroup.Thestudygroupwasgivenintravenousanesthesiacombinedwithepiduralanesthesia,andthecontrolgroupwasgivenconventionalintravenousanesthesia.Thephysiologicalindicatorsofbothgroupswereobservedduringtheoperation,andtheoperationtime,postoperativerecoverytime,andpostoperativecomplicationsofpatientswererecorded.

Results:Theoperationtime,postoperativerecoverytime,lungfunctionrecoverytime,andpostoperativecomplicationrateinthestudygroupweresignificantlybetterthanthoseinthecontrolgroup.Theanalgesiceffectinthestudygroupwasalsobetter,andtheanalgesictimewaslonger.Thepostoperativepainscoreinthestudygroupwaslowerthanthatinthecontrolgroup,andthepatient'scomfortlevelwashigher.Therewasnosignificantdifferenceinthephysiologicalindicatorsofbothgroupsbeforeandafterthesurgery.

Conclusion:Needle-drugcombinedanesthesiacansignificantlyreducethesurgicalriskofthoracoscopiclobectomy,minimizecomplications,shortenpostoperativerecoverytime,andimprovethequalityoflifeofpatientsaftersurgery.

Keywords:needle-drugcombinedanesthesia,thoracoscopicsurgery,lobectomy,recoveryperiod,postoperativecomplication。Thoracoscopiclobectomyhasbecomethepreferredsurgicalapproachforthetreatmentoflungcancerduetoitsminimallyinvasivenatureandexcellentvisualfield.However,thissurgeryisstillassociatedwithriskssuchashemodynamicinstability,intraoperativepain,andcomplicationsduringthepostoperativeperiod.Therefore,itisessentialtoadopteffectiveanesthesiamethodstoreducesurgicalrisksandimprovepostoperativeoutcomes.

Inrecentyears,needle-drugcombinedanesthesiahasbeenwidelyusedinthoracoscopiclobectomyduetoitsadvantagesinreducingsurgicalrisksandimprovingthepostoperativeperiod.Thisanesthesiamethodinvolvesadministeringlocalanesthesiatotheincisionsiteandcombiningitwithintravenousanestheticsandanalgesicstomaintainsedationandpaincontrolduringthesurgery.Comparedwithgeneralanesthesia,needle-drugcombinedanesthesiareducestheamountofanestheticandanalgesicdrugsused,reducestheincidenceofcomplicationssuchasnauseaandvomiting,andshortensthepostoperativerecoverytime.

Severalstudieshavereportedtheeffectivenessofneedle-drugcombinedanesthesiainthoracoscopiclobectomy.Forinstance,onestudyinvestigatedtheeffectsofneedle-drugcombinedanesthesiaonthehemodynamicstabilityandpostoperativerecoveryinpatientsundergoingthoracoscopiclobectomy.Thestudyfoundthatthisanesthesiamethodsignificantlyreducedtheincidenceofintraoperativehemodynamicinstability,postoperativepain,andnauseaandvomitingincomparisonwithgeneralanesthesia.

Anotherstudyinvestigatedtheimpactofneedle-drugcombinedanesthesiaonthequalityoflifeofpatientsafterthoracoscopiclobectomy.Thestudyfoundthatthisanesthesiamethodreducedpostoperativepainanddiscomfort,improvedtheemotionalandsocialaspectsofpatients'qualityoflife,andresultedinoverallhigherlevelsofpatientsatisfaction.

Inconclusion,needle-drugcombinedanesthesiaisaneffectiveanesthesiamethodforthoracoscopiclobectomythatcansignificantlyreducesurgicalrisks,minimizecomplications,shortenpostoperativerecoverytime,andimprovethequalityoflifeofpatientsaftersurgery.Healthcareprovidersshouldconsiderusingthisanesthesiamethodinpatientsundergoingthoracoscopiclobectomytooptimizetheirpostoperativeoutcomes。Furthermore,inadditiontothebenefitsdiscussedabove,theuseofneedle-drugcombinedanesthesiacanalsoleadtocostsavingsforpatientsandhealthcareproviders.Onestudyfoundthattheoverallcostofanesthesiawaslowerforpatientswhoreceivedneedle-drugcombinedanesthesiacomparedtothosewhoreceivedgeneralanesthesiaduringthoracoscopiclobectomy.Thisisbecausetheuseoflocalanesthesiareducestheneedforexpensivedrugsandequipmentthatarerequiredforgeneralanesthesia,aswellastheneedforlongerhospitalstaysandpostoperativecare.

Itisimportanttonotethatwhileneedle-drugcombinedanesthesiaoffersnumerousbenefits,itmaynotbesuitableforallpatients.Patientswithcertainmedicalconditions,suchasseverelungorheartdisease,maynotbegoodcandidatesforthistypeofanesthesia.Additionally,thesuccessofthismethoddependsontheskillandexperienceofthehealthcareprovideradministeringtheanesthesia.Assuch,healthcareprovidersshouldundergoappropriatetrainingandhavesufficientexperiencebeforeperformingneedle-drugcombinedanesthesiainordertoensurethesafetyoftheirpatients.

Inconclusion,needle-drugcombinedanesthesiaisasafeandeffectiveoptionforanesthesiaduringthoracoscopiclobectomy.Byreducingtherisksassociatedwithgeneralanesthesiaandimprovingpostoperativeoutcomes,thismethodcanenhancetheoverallqualityofcareprovidedtopatientsundergoingthisprocedure.Healthcareprovidersshouldconsiderincorporatingneedle-drugcombinedanesthesiaintotheirpracticewhenappropriate,andcontinuetomonitoritseffectivenessandsafetyinordertooptimizepatientcare。Inadditiontoitsuseinthoracoscopiclobectomy,needle-drugcombinedanesthesiahasalsobeenstudiedandutilizedinothersurgicalprocedures,suchaslaparoscopiccholecystectomyandgynecologicalsurgeries.Thismethodhasbeenfoundtooffersimilarbenefitsintermsofreducedriskandimprovedpostoperativeoutcomes.

However,itisimportanttonotethatnotallpatientsmaybeappropriatecandidatesforthistypeofanesthesia.Patientswithcertainmedicalconditions,suchassevererespiratorydiseaseorallergytolocalanesthetics,maynotbeabletotolerateneedle-drugcombinedanesthesia.Additionally,theavailabilityofqualifiedanesthesiologistsandspecializedequipmentmaylimittheuseofthismethodinsomehealthcaresettings.

Aswithanymedicalintervention,thesafetyandeffectivenessofneedle-drugcombinedanesthesiashouldbecontinuouslymonitoredandevaluated.Futureresearchshouldaimtoidentifyanypotentiallong-termimpactsonpatientoutcomes,aswellasidentifyanypatientpopulationswhomaybenefitmostfromthismethod.

Inconclusion,needle-drugcombinedanesthesiaisapromisingoptionforanesthesiaduringthoracoscopiclobectomyandothersurgicalprocedures.Itsabilitytoreduceriskandimprovepostoperativeoutcomescanenhancetheoverallqualityofcareprovidedtopatients.Healthcareprovidersshouldconsiderincorporatingthismethodintotheirpracticewhenappropriate,whilealsocarefullyevaluatingandmonitoringitssafetyandefficacy。Additionally,needle-drugcombinedanesthesiamayalsohaveeconomicbenefits.Asitallowsformoreprecisecontroloveranesthesiaandreducestheneedforhigherdosesofopioidsandothermedications,itmayhelptodecreasetheoverallcostofcare.Furthermore,asitcanpotentiallyreducetheriskofcomplicationsandtheneedforlongerhospitalstays,itmayalsoleadtoreducedhealthcareexpensesoverall.

However,itisimportanttoacknowledgethatthismethodmaynotbesuitableforallpatientsorsurgicalprocedures.Everypatientisunique,andfactorssuchasmedicalhistory,age,andthespecificprocedurebeingperformedneedtobetakenintoaccountwhendeterminingthemostappropriateanesthesiaapproach.Additionally,healthcareprovidersmustensurethattheyhavethenecessarytraining,equipment,andresourcestosafelyandeffectivelyadministerthistypeofanesthesia.

Inconclusion,needle-drugcombinedanesthesiashowsgreatpromiseasasafeandeffectiveoptionfor